The Linda and Les Vinney Scholar Program in Alzheimer's disease ("Vinney Scholar Program") provides funding and drug development support to researchers whose work aims to treat or prevent Alzheimer's disease. Each year up to three Vinney Scholars are chosen. The award includes:
- One-year grant
- $100,000 guaranteed (base award)
- Potential to qualify for additional up to $50,000 project acceleration support
- Drug development expertise and project management support
- A personalized team of drug developers and project manager for each award recipient
- Expert business, commercialization and clinical development advice
Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
- MD or PhD (or equivalent)
- Faculty position at an accredited academic medical center, university or research institution in the US, Canada, or UK, and conduct the majority of their research at that institution
- A project must have a single Principal Investigator (PI) who will be named the Vinney Scholar and who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.
- Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.
The Vinney Scholar Program selection committee seeks breakthrough discoveries that demonstrate innovation, creativity and potential for clinical impact, including:
- Discoveries deemed to address unmet medical needs
- Modulators of novel targets
- Potential to be developed into a commercial program
- Strong intellectual property (IP) or protection strategy
- May be a small molecule, biologic, or other therapeutic modality
- Diagnostics or devices only acceptable as part of a therapeutic development project